metricas
covid
Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Avances en el cribado del cáncer colorrectal
Journal Information
Vol. 31. Issue S4.
Jornada de Actualización en Gastroenterología Aplicada
Pages 62-65 (October 2008)
Share
Share
Download PDF
More article options
Vol. 31. Issue S4.
Jornada de Actualización en Gastroenterología Aplicada
Pages 62-65 (October 2008)
Jornada de actualización en gastroenterología aplicada
Full text access
Avances en el cribado del cáncer colorrectal
Visits
2479
Rodrigo Jover Martínez
Corresponding author
jover_rod@gva.es

Correspondencia: Unidad de Gastroenterología. Hospital General Universitario de Alicante. Pintor Baeza, 12. 03010 Alicante. España.
Unidad de Gastroenterología. Hospital General Universitario de Alicante. Alicante. España
This item has received
Article information
Resumen

El cáncer colorrectal es una de las neoplasias más prevalentes en nuestro medio y reúne varias características que la hacen una enfermedad propicia para el establecimiento de medidas de cribado poblacional. Sin embargo, todavía no está bien establecido cuál es el mejor procedimiento para el cribado del cáncer colorrectal en población de riesgo medio. En esta revisión se discuten las novedades más importantes, presentadas en el congreso de la American Gastroenterological Association, en cuanto a cribado de cáncer colorrectal, con especial énfasis en los estudios que comparan diferentes estrategias. Por otra parte, también se revisan novedades referentes al cribado y la vigilancia en la población de alto riesgo.

Palabras clave:
Cribado
Cáncer colorrectal
Test de sangre oculta en heces
Prevención
Colonoscopia
Abstract

Colorectal cancer is one of the most prevalent neoplasms in our environment. Because of its characteristics, this disease is suitable for populational screening. However, the best procedure for screening for colorectal cancer in the population at intermediate risk has not been well defined. The present article discusses the most important advances in colorectal cancer screening presented in the meeting of the American Gastroenterological Association, with special emphasis on studies comparing different strategies. Advances in screening and surveillance of the population at high risk are also reviewed.

Key words:
Screening
colorectal cancer
fecal occult blood test
prevention
colonoscopy
Full text is only aviable in PDF
Bibliografía
[1.]
L. Van Rossum, A.F. Van Rijn, R. Laheij, A.L. Verbeek, M.G. Van Oijen, P. Fockens, et al.
Randomized study comparing the test performance of a guaiac-based fecal occult blood test with an immunochemical fecal occult blood test for colorectal cancer screening in a screening population.
Gastroenterology, 134 (2008), pp. A619
[2.]
L.G. Van Rossum, A.F. Van Rijn, R.J. Laheij, M.G. Van Oijen, P. Fockens, H.H. Van Krieken, et al.
Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
Gastroenterology, 135 (2008), pp. 82-90
[3.]
L. Hol, M.E. Van Leerdam, M. Van Ballegooijen, A. Van Vuuren, J.C. Reijerink-Verheij, A.C. Van der Togt, et al.
Attendance to screening for colorectal cancer in the Netherlands: Randomized controlled trial comparing two different forms of fecal occult blood tests and sigmoidoscopy.
Gastroenterology, 134 (2008), pp. A621
[4.]
M. Sauer, S.J. Sontag, T.G. Schnell, J. Leya.
Mandated screening of all veterans for colorectal cancer: the FONT versus the C-scope.
Gastroenterology, 134 (2008), pp. A260
[5.]
W.K. Leung, J.Y. Lau, B.Y. Suen, G. Wong, D.K. Chow, L. Lai, et al.
Colonoscopic screening at 5-year after initial examination in average risk subjects: a prospective study.
Gastroenterology, 134 (2008), pp. A623
[6.]
A.G. Zauber, I. Landrosp-Vogelaar, J. Wilschut, A.B. Knudsen, J.I. Allen, J.V. Brill, et al.
Prevention of colorectal cancer by colonoscopy is the most likely screening strategy to offset escalating treatment costs.
Gastroenterology, 134 (2008), pp. A1010
[7.]
M.E. Benson, P. Dureja, D.V. Gopal, M. Reicheldefer, D.H. Kim, P.J. Pickhardt, et al.
A comparison of overall adenoma detection and recovery rate of optical colonoscopy and CT colonography.
Gastroenterology, 134 (2008), pp. A439
[8.]
D.K. Rex, A. Overhiser, S. Chen.
American College of Radiology recommendations for CT colonography interpretation: implication for resection of high risk adenoma findings.
Gastroenterology, 134 (2008), pp. A878
[9.]
S. Sharma, A. Ata, S. Richter.
The characteristics of small and diminutive colorectal polyps as seen on conventional colonoscopy.
Gastroenterology, 134 (2008), pp. A424
[10.]
F. Tsai, W. Strum.
Family history of single first-degree relative with colorectal cancer does not predict increased risk of advanced adenomas on screening colonoscopy in southwestern US population.
Gastroenterology, 134 (2008), pp. A272
[11.]
A. Ferrández, R. Sainz, A.I. Lanas.
Risk of neoplasia in first-degree relatives of patients with colorectal cancer. Results of a prospective region-wide colonoscopy screening program.
Gastroenterology, 134 (2008), pp. S1129
[12.]
P.M. Lynch, D.S. Saraiya.
Non-surgical management of attenuated familial adenomatous polyposis: results of a long-term surveillance program.
Gastroenterology, 134 (2008), pp. S1029
[13.]
H.F. Vasen, F.M. Nagengast, M. Van Kouwen, A. Langers, J.W. Poley, A. Cats, et al.
The outcome of longterm surveillance of Lynch syndrome families in the Netherlands.
Gastroenterology, 134 (2008), pp. T2031
[14.]
M. Van Lier, J. De Wilt, J. Wagemakers, R. Damhuis, E.J. Kuipers.
Van Leerdam Poor compliance with MSI-analysis in patients with colorectal cancer at high risk for Lynch syndrome.
Gastroenterology, 134 (2008), pp. T2040
Copyright © 2008. Elsevier España S.L.. Todos los derechos reservados
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos